AR

Ayyappasamy Raja Rajeshwar

Active Director Director DIN 01821522
DIN 01821522 First appointment Mar 2008 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Ayyappasamy Raja Rajeshwar

Data last updated:

Ayyappasamy Raja Rajeshwar is a Director at Tamilnadu Medical Pharma Private Limited (since 2008). The company operates in Healthcare.

DIN 01821522
Primary Designation Director
Industry Healthcare
First Appointment 10 Mar 2008
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Mar 20082004Active

Board colleagues of Ayyappasamy Raja Rajeshwar

NameDINCompanyDesignation
Kuppusamy Pari01821530Tamilnadu Medical Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tamilnadu Medical Pharma Private Limited
Premium access

Shareholding and investment profile for Ayyappasamy Raja Rajeshwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ayyappasamy Raja Rajeshwar

Ayyappasamy Raja Rajeshwar currently holds 1 directorship: Tamilnadu Medical Pharma Private Limited (Director, since 10 Mar 2008).

Ayyappasamy Raja Rajeshwar was first appointed on 10 Mar 2008 as Director at Tamilnadu Medical Pharma Private Limited.

The current boards of Ayyappasamy Raja Rajeshwar's companies include Kuppusamy Pari (Tamilnadu Medical Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available